WebMar 15, 2024 · Kurve has filed a Form 1-A preliminary offering circular with the U.S. Securities and Exchange Commission (SEC) for a Regulation A+ $50 million funding round [kurvetx.com/offering-circular].... WebKurve Therapeutics is totally focused on neurodegenerative diseases. With the one exception of us doing oncology and treating brain tumors, were doing a new mechanism of action by bypassing the blood brain barrier. So there's a couple of ways of doing this one is to cross overusing and diffusion one is to buy Platt bypass it using the nasal cavity.
Silver Lining Consortium Alzheimer
WebSep 14, 2024 · Next-generation Medtech innovator Kurve Therapeutics begins an equity crowdfunding journey with its $50 million Regulation A+ raise. Private investors can now invest in a company aiming to disrupt and transform a $1.3 trillion dementia market alone while benefiting millions living with neurodegenerative diseases. WebMar 15, 2024 · Kurve has filed a Form 1-A preliminary offering circular with the U.S. Securities and Exchange Commission (SEC) for a Regulation A+ $50 million funding round … bruno pitchers
Kurve Therapeutics, Innovative Medtech and Specialty-Drug …
WebAug 9, 2024 · Funding Round • Aug 6, 2009. Kurve Therapeutics raised $2,028,581 / Series Unknown. Discover more funding rounds. News • Jun 23, 2007. Engadget — ViaNase electronic atomizers futurize nasal spray. Funding Round • Feb 4, 2004. Kurve Therapeutics raised $800,000 / Angel. Discover more funding rounds. View All. WebJun 14, 2024 · Kurve Therapeutics' innovative technology and drug formulations have been featured in 18 peer-reviewed publications in leading medical journals with further … WebAug 9, 2024 · Kurve Therapeutics has raised a total of $53.5M in funding over 6 rounds. Their latest funding was raised on Aug 9, 2024 from a Series A round. Which funding types raised the most money? bruno philosophy